课题基金 / 基金详情

Structure-based, Rational Design of RhoGEF, GGTase I and RhoKinase Inhibitors

Structure-based, Rational Design of RhoGEF, GGTase I and RhoKinase Inhibitors
基于结构的 RhoGEF、GGTase I 和 RhoKinase 抑制剂的合理设计
批准号:
7882864
负责人:
Nicolas Lawrence
金额:
$30.93万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Protein-protein Interactions (PPIs) play critical roles in biological processes that can propagate or terminate llfe.These PPIs have been Implicated In numerous disease states, including HIV, diabetes, and cardiovascular and neurodegenerative diseases, making them Important targets for dIsruptlon.Often recognition between proteins is mediated by protein secondary structures, such as a-helices, via one helical face, where interacting residues occupy predominantly the /, / + 3 or / + 4, and / + 7 positions. Accordingly, these surfaces are critical targets for small molecule mimicry. Our previous focus has yielded a-helix mimetics with Inherent disadvantages, either poor solubility (terphenyl and terpyridine scaffolds) or hydrogen-bonding networks to maintain their correct orientation (terephthalamide and thspyrldylamlde scaffolds). As a mechanism to overcome the disadvantages of our previous designs, we have reported an Innovative scaffold that replaces the terminal six-membered aromatic end units with water-soluble five-membered heterocyclic groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金